Form 4: Kamada Ltd. Director Reports Stock Option Transactions

Kamada Ltd. Director Karnit Goldwasser reported transactions involving employee stock options on April 7, 2026.

Summary

• Director Karnit Goldwasser reported transactions related to employee stock options for Kamada Ltd. (KMDA) on April 7, 2026.
• These transactions involved the acquisition and disposal of multiple employee stock options with exercise prices ranging from $5.87 to $7.48.
• The options are exercisable at various dates between March 25, 2021, and December 22, 2026, with expiration dates generally set for September 25, 2026, or June 22, 2029.
• The exercise prices were adjusted due to a cash dividend distribution declared on March 11, 2026, as per the Company's 2011 Share Award Plan.
• All reported securities are beneficially owned indirectly and held by a trustee under the Company's 2011 Share Award Plan.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports routine insider transactions and option adjustments rather than significant strategic or financial performance news.

Positives

• Director Goldwasser's transactions indicate continued engagement with the company's equity incentive plans.
• The adjustment of option prices due to a dividend distribution suggests a mechanism to protect option holders' value.

Negatives

• The filing details disposals of stock options, which could be interpreted as a reduction in direct beneficial ownership, though this is mitigated by the trustee holding.
• The specific reasons for the acquisition and disposal of options on the same date are not detailed, leaving room for speculation.

Risks

• The value of the stock options is subject to market fluctuations and the company's future performance.
• Changes in exchange rates could affect the actual cost of exercising options when converted from NIS to USD.

Future Outlook

The filing does not contain forward-looking statements or guidance. It solely reports on past transactions.

Management Comments

• The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award.
• Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.
• All exercise prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of April 6, 2026.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions in the biotechnology and pharmaceutical sectors, where equity-based compensation is common for incentivizing management and directors.

Corporate Governance

Stakeholder Impact

• Shareholders: The transactions themselves do not directly impact share price, but they reflect management's ongoing participation in equity plans, which can be viewed positively.
• Employees: The adjustment of option prices due to dividends ensures that the value of equity awards remains protected, aligning employee interests with shareholder value.
• Directors: Karnit Goldwasser, as a director, is directly involved in these option transactions and their adjustments.

Next Steps

• Continued monitoring of insider transactions for any significant shifts in beneficial ownership.
• Tracking the vesting and potential exercise of these stock options based on future company performance and stock price.

Key Dates

Keywords

Kamada Ltd., KMDA, Form 4, Stock Options, Beneficial Ownership, Director Transactions, SEC Filing, Employee Stock Options, Karnit Goldwasser, Equity Incentive Plan